Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -9269.8% | $ -46.35M | $ 500K |
3/31/2025 | 0% | $ -48.66M | $ 0 |
12/31/2024 | 0% | $ -47.36M | $ 0 |
6/30/2024 | -3554.66% | $ -38.75M | $ 1.09M |
12/31/2023 | -284.16% | $ -28.42M | $ 10M |
6/30/2023 | -444.28% | $ -39.59M | $ 8.91M |
12/31/2022 | 0% | $ -54.46M | $ 0 |
6/30/2022 | 0% | $ -53.04M | $ 0 |
12/31/2021 | -57.11% | $ -26.03M | $ 45.58M |
6/30/2021 | -56.64% | $ -25.82M | $ 45.58M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for MEREO BIOPHARMA GROUP PLC is calculated as follows: Op. Inc. [ $ -60.55M ] / Revenues [ $ 0 ]
(=) Operating % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -71.54% |
max | 83.41% |
average | 9.04% |
median | 8.77% |
std | 23.7% |